Ratings by H.C. Wainwright (Sean Lee)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/12/2026 | Senseonics Holdings | SENS | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2026 | Novavax | NVAX | Maintain | Buy (Buy) |
|
Details | ||
| 3/26/2026 | CytoSorbents | CTSO | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/27/2026 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2026 | Kazia Therapeutics | KZIA | Maintain | Buy (Buy) |
|
Details | ||
| 1/23/2026 | Plus Therapeutics Inc. | PSTV | Maintain | Buy (N/A) |
|
Details | ||
| 1/21/2026 | Corvus Pharmaceuticals | CRVS | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2025 | Kazia Therapeutics | KZIA | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2025 | Plus Therapeutics Inc. | PSTV | Maintain | Buy (Buy) |
|
Details | ||
| 11/6/2025 | Senseonics Holdings | SENS | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2025 | Plus Therapeutics Inc. | PSTV | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2025 | Kazia Therapeutics | KZIA | Maintain | Buy (Buy) |
|
Details | ||
| 10/24/2025 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2025 | Dogwood Therapeutics, Inc. | DWTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2025 | Akari Therapeutics | AKTX | Maintain | Buy (Buy) |
|
Details | ||
| 9/5/2025 | Senseonics Holdings | SENS | Maintain | Buy (Buy) |
|
Details | ||
| 8/28/2025 | Novavax | NVAX | New Coverage | Buy (N/A) |
7.58 (9.00) |
18.73% | Details | |
| 7/10/2025 | Kazia Therapeutics | KZIA | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2025 | Senseonics Holdings | SENS | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2025 | Plus Therapeutics Inc. | PSTV | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2025 | Senseonics Holdings | SENS | New Coverage | Buy (N/A) |
0.52 (6.26) |
1103.85% | Details | |
| 4/23/2025 | Dogwood Therapeutics, Inc. | DWTX | Upgrade | Buy (Neutral) |
5.46 (1.55) |
-71.61% | Details | |
| 3/28/2025 | Plus Therapeutics Inc. | PSTV | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2025 | Corvus Pharmaceuticals | CRVS | Maintain | Buy (Buy) |
|
Details | ||
| 3/11/2025 | Myomo Inc. | MYO | Maintain | Buy (N/A) |
|
Details | ||
| 1/2/2025 | Corvus Pharmaceuticals | CRVS | New Coverage | Buy (N/A) |
5.35 (12.63) |
136.07% | Details | |
| 11/26/2024 | Plus Therapeutics Inc. | PSTV | Maintain | Buy (Buy) |
|
Details | ||
| 11/15/2024 | Plus Therapeutics Inc. | PSTV | Maintain | Buy (Buy) |
|
Details | ||
| 11/11/2024 | Monopar Therapeutics | MNPR | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2024 | Virios Therapeutics | VIRI | Maintain | Neutral (N/A) |
|
Details | ||
| 10/1/2024 | Gritstone bio | GRTS | Downgrade | Neutral (Buy) |
0.58 (0.03) |
-94.83% | Details | |
| 8/12/2024 | Monopar Therapeutics | MNPR | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | Virios Therapeutics | VIRI | Maintain | Neutral (N/A) |
|
Details | ||
| 7/12/2024 | Kazia Therapeutics | KZIA | Maintain | Buy (Buy) |
|
Details | ||
| 5/15/2024 | CASI Pharmaceuticals | CASI | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2024 | Gritstone bio | GRTS | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2023 | Plus Therapeutics Inc. | PSTV | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2023 | Monopar Therapeutics | MNPR | Maintain | Buy (N/A) |
|
Details | ||
| 4/11/2023 | Kazia Therapeutics | KZIA | Upgrade | Buy (Neutral) |
1.09 (14.69) |
1247.71% | Details | |
| 4/3/2023 | ThermoGenesis Holdings | THMO | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2022 | Akari Therapeutics | AKTX | New Coverage | Buy (N/A) |
0.54 (11.79) |
2083.33% | Details | |
| 11/7/2022 | Gritstone Oncology | GRTS | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2022 | Virios Therapeutics | VIRI | Downgrade | Neutral (Buy) |
2.00 (0.16) |
-92% | Details | |
| 8/2/2022 | Kazia Therapeutics | KZIA | Downgrade | Neutral (Buy) |
1.92 (14.69) |
665.1% | Details | |
| 7/22/2022 | Plus Therapeutics Inc. | PSTV | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2021 | Virios Therapeutics | VIRI | New Coverage | Buy (N/A) |
4.58 (0.16) |
-96.51% | Details | |
| 11/1/2021 | Monopar Therapeutics | MNPR | New Coverage | Buy (N/A) |
4.80 (81.77) |
1603.54% | Details | |
| 3/18/2021 | ThermoGenesis Holdings | THMO | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2021 | Plus Therapeutics Inc. | PSTV | New Coverage | Buy (N/A) |
3.75 (4.08) |
8.8% | Details | |
| 1/20/2021 | Gritstone Oncology | GRTS | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2021 | Kazia Therapeutics | KZIA | New Coverage | Buy (N/A) |
8.98 (14.69) |
63.59% | Details | |
| 4/17/2020 | ThermoGenesis Holdings | THMO | Maintain | Buy (N/A) |
|
Details |
